1. Introduction
===============

*Achyranthes bidentata* Blume (Amaranthaceae) is widely distributed in Asian countries like India, Korea, Japan, and China. The root of *A. bidentata* has been prescribed in the Chinese Pharmacopeia as an important herbal medicine and its multiple pharmacological effects, such as anti-osteoporosis \[[@B1-molecules-17-03324],[@B2-molecules-17-03324]\], antitumor \[[@B3-molecules-17-03324],[@B4-molecules-17-03324],[@B5-molecules-17-03324]\], anti-senility \[[@B3-molecules-17-03324],[@B6-molecules-17-03324],[@B7-molecules-17-03324],[@B8-molecules-17-03324]\], anti-inflammatory \[[@B9-molecules-17-03324]\], immunomodulatory \[[@B3-molecules-17-03324],[@B10-molecules-17-03324],[@B11-molecules-17-03324],[@B12-molecules-17-03324],[@B13-molecules-17-03324]\] activities are well documented. Previous phytochemical investigations of *A. bidentata* have reported the isolation of phytoecdysteroids \[[@B14-molecules-17-03324],[@B15-molecules-17-03324],[@B16-molecules-17-03324]\], saccharides \[[@B17-molecules-17-03324],[@B18-molecules-17-03324]\] and saponins \[[@B19-molecules-17-03324],[@B20-molecules-17-03324]\], and some of them displayed diverse bioactivities. In the course of our search for potentially new and bioactive compounds from medicinal plants in China, we investigated the roots of *A. bidentata* and isolated eight phytoecdysteroids, including two new ones, (25*S*)-20,22-*O*-(*R*-ethylidene)inokosterone (**1**) and 20,22-*O*-(*R*-3-methoxycarbonyl)propylidene-20-hydroxyecdysone (**2**), and six known phytoecdysteroids **3--8** ([Figure 1](#molecules-17-03324-f001){ref-type="fig"}). In this paper, we report the isolation and structural elucidation of these phytoecdysteroids.

![Chemical structures of compounds **1**--**8***.*](molecules-17-03324-g001){#molecules-17-03324-f001}

2. Results and Discussion
=========================

Compound **1** was obtained as a white amorphous powder with a molecular formula of C~29~H~46~O~7~ as established on the basis of a combined analysis of its HRESIMS and NMR spectroscopic data. The spectroscopic data (IR, UV, and NMR: see [Section 3.3.](#sec3dot3-molecules-17-03324){ref-type="sec"} and [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}) supported the fact that **1** was an ecdysteroid closely related to inokosterone-20,22-acetonide, a reported \[[@B21-molecules-17-03324],[@B22-molecules-17-03324]\] ecdysteroid compound which was also obtained as compound **3** in the present study. Careful analysis of the ^1^H- and ^13^C-NMR spectra pointed out as major differences that the resonances for the acetone ketal group in **3** were replaced by the signals for a C~2~ acetal group \[*δ*~H~ 5.05 (1H, q, H-1\'), 1.29 (3H, d, H~3~-2\'); *δ*~C~ 102.3 (C-1\'), 22.0 (C-2\')\]. These data led us to preliminarily establish the whole structure of **1** as 20,22-ethylideneinokosterone, of which the stereochemistry at C-25 and C-1\' still needed to be determined. In the ^1^H-^1^H COSY spectrum, signals correlated to the connections of C-22 to C-27 were exhibited. In the NOESY spectrum, a significant correlation signal of H-1\' (*δ*~H~ 5.05) with H-22 (*δ*~H~ 3.65) was observed, which indicated that the stereochemistry at C-1\' in **1** should be *R* configuration ([Figure 2](#molecules-17-03324-f002){ref-type="fig"}). In order to clarify the absolute configuration at C-25 in the molecule, an acid hydrolysis of **1** was carried out, and the centre ecdysteroid unit that released from **1** was confirmed to be the same as the known compound (25*S*)-inokosterone (**8**), as evidenced by a co-TLC elution test and comparison of the NMR spectroscopic data with literature precedents \[[@B23-molecules-17-03324]\]. This result indicated that the absolute configuration at C-25 of **1** should be *S*. Thus, the complete structure of **1** was elucidated as (25*S*)-20,22-*O*-(*R*-ethylidene)inokosterone.
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###### 

The ^1^H-NMR (400 MHz) spectral data \[*δ* (ppm), *J* in Hz\] of **1**--**4** and **8**.

  No.                    *δ*~H~ (1) ^a^         *δ*~H~ (2) ^a^         *δ*~H~ (3) ^a^         *δ*~H~ (4) ^a^         *δ*~H~ (8) ^b^
  ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- ----------------------
  1                      1.77 (m), 1.41(m)      1.78 (m)               1.78 (m)               1.79(m)                2.15 (m), 1.93 (m)
  2                      3.82 (m)               3.82 (m)               3.82 (m)               3.82 (m)               4.19 (m)
  3                      3.94 (m)               3.94 (m)               3.94 (m)               3.94 (m)               4.23 (m)
  4                      1.73 (m), 1.69 (m)     1.71 (m)               1.73 (m), 1.69 (m)     1.72 (m)               2.04 (m), 1.82 (m)
  5                      2.38 (m)               2.36 (m)               2.37 (m)               2.35 (m)               3.01 (dd, 13.2, 3.2)
  7                      5.80 (d, 2.0)          5.81 (s)               5.80 brs               5.80 (d, 2.0)          6.26 (d, 1.6)
  9                      3.13 (m)               3.13 (m)               3.13 (m)               3.13 (m)               3.60 (m)
  11                     1.79 (m), 1.67 (m)     1.79 (m), 1.68 (m)     1.79 (m), 1.67 (m)     1.78 (m), 1.68 (m)     1.88 (m), 1.73(m)
  12                     2.09 (m), 1.82 (m)     2.09 (m), 1.83 (m)     2.09 (m), 1.82 (m)     2.09 (m), 1.83 (m)     2.17 (m), 1.92 (m)
  15                     1.94 (m), 1.60 (m)     1.91 (m), 1.61 (m)     1.94 (m), 1.60 (m)     1.91 (m), 1.61 (m)     2.60 (m), 2.04 (m)
  16                     1.92 (m), 1.87 (m)     1.92 (m)               1.92 (m), 1.87 (m)     1.93 (m)               2.46 (m), 2.08 (m)
  17                     2.32 (m)               2.34 (m)               2.28 (m)               2.32 (m)               2.95 (t, 9.2)
  18                     0.85 (s)               0.84 (s)               0.81 (s)               0.85 (s)               1.22 (s)
  19                     0.95 (s)               0.95 (s)               0.95 (s)               0.96 (s)               1.07 (s)
  21                     1.13 (s)               1.15 (s)               1.15 (s)               1.15 (s)               1.59 (s)
  22                     3.65 (dd, 8.8, 3.6)    3.64 (m)               3.68 (dd, 9.6, 2.8)    3.63 (m)               3.86 (d, 10.4)
  23                     1.49 (m)               1.54 (m)               1.47 (m)               1.52 (m)               1.94 (m), 1.63 (m)
  24                     1.50 (m), 1.15 (m)     1.72 (m), 1.45 (m)     1.68 (m), 1.15 (m)     1.71 (m)               2.17 (m), 1.41 (m)
  25                     1.61 (m)                                      1.63 (m)                                      1.81 (m)
  26                     3.34 (dd, 10.4, 6.4)   1.19 (s)               3.34 (dd, 10.4, 6.4)   1.19 (s)               3.64 (dd, 10.0, 6.4)
  3.42 (dd, 10.4, 5.6)                          3.42 (dd, 10.4, 5.6)                          3.76 (dd, 10.0, 5.2)   
  27                     0.93 (d, 6.8)          1.20 (s)               0.93 (d, 6.4)          1.20 (s)               1.03 (d, 6.4)
  1\'                    5.05 (q, 4.8)          4.97 (t, 4.0)                                 5.05 (q, 4.8)          
  2\'                    1.29 (d, 4.8)          1.90 (m)               1.30 (s)               1.29 (d, 4.8)          
  3\'                                           2.41 (t, 7.2)          1.37 (s)                                      
  4\'-OC[H]{.ul}~3~                             3.65 (s)                                                             

^a^ Data were measured in CD~3~OD; ^b^ Data were measured in C~5~D~5~N.
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###### 

The ^13^C-NMR (100 MHz) spectral data \[*δ* (ppm)\] of compounds **1**--**4** and **8**.

  Position            *δ*~C~ (1) ^a^   *δ*~C~ (2) ^a^   *δ*~C~ (3) ^a^   *δ*~C~ (4) ^a^   *δ*~C~ (8) ^b^
  ------------------- ---------------- ---------------- ---------------- ---------------- ----------------
  1                   37.3 (t)         37.3 (t)         37.3 (t)         37.3 (t)         38.0 (t)
  2                   68.7 (d)         68.7 (d)         68.7 (d)         68.7 (d)         68.1
  3                   68.5 (d)         68.5 (d)         68.5 (d)         68.5 (d)         68.1
  4                   32.9 (t)         32.8 (t)         32.8 (t)         32.9 (t)         32.5 (t)
  5                   51.8 (d)         51.8 (d)         51.8 (d)         51.8 (d)         51.4 (d)
  6                   206.4 (s)        206.5 (s)        206.4 (s)        206.4 (s)        203.5 (s)
  7                   122.2 (d)        122.2 (d)        122.2 (d)        122.1 (d)        121.7 (d)
  8                   167.5 (s)        167.6 (s)        167.6 (s)        167.6 (s)        166.1 (s)
  9                   35.1 (d)         35.1 (d)         35.1 (d)         35.1 (d)         34.5 (d)
  10                  39.2 (s)         39.2 (s)         39.2 (s)         39.2 (s)         38.7 (s)
  11                  21.5 (t)         21.5 (t)         21.5 (t)         21.5 (t)         21.1 (t)
  12                  32.2 (t)         32.2 (t)         32.3 (t)         32.1 (t)         31.8 (t)
  13                  49.0 (s) \*      49.0 (s) \*      49.0 (s) \*      49.0 (s) \*      48.1 (s)
  14                  85.2 (s)         85.2 (s)         85.3 (s)         85.2 (s)         84.2 (s)
  15                  31.7 (t)         31.7 (t)         31.7 (t)         31.7 (t)         32.1 (t)
  16                  22.6 (t)         22.6 (t)         22.4 (t)         22.6 (t)         21.7 (t)
  17                  51.3 (d)         51.4 (d)         50.5 (d)         51.3 (d)         50.1 (d)
  18                  17.6 (q)         17.6 (q)         17.6 (q)         17.6 (q)         17.9 (q)
  19                  24.4 (q)         24.4 (q)         24.4 (q)         24.4 (q)         24.5 (q)
  20                  85.3 (s)         85.3 (s)         85.7 (s)         85.3 (s)         77.3 (s)
  21                  23.6 (q)         23.4 (q)         22.5 (q)         23.7 (q)         21.5 (q)
  22                  85.5 (d)         85.6 (d)         83.1 (d)         85.6 (d)         76.8 (d)
  23                  27.3 (t)         24.6 (t)         27.4 (t)         24.6 (t)         30.3 (t)
  24                  32.0 (t)         42.2 (t)         32.0 (t)         42.2 (t)         32.0 (t)
  25                  37.0 (d)         71.1 (s)         37.0 (d)         71.1 (s)         36.8 (d)
  26                  68.2 (t)         29.5 (q)         68.2 (t)         29.5 (q)         67.4 (t)
  27                  17.0 (q)         28.9 (q)         17.0 (q)         28.9 (q)         17.8 (q)
  1\'                 102.3 (d)        103.9 (d)        108.0 (s)        102.3 (d)        
  2\'                 22.0 (q)         31.0 (t)         29.3 (q)         22.0 (q)         
  3\'                                  29.2 (t)         27.2 (q)                          
  4\'                                  175.6 (s)                                          
  4\'-O[C]{.ul}H~3~                    52.1 (q)                                           

^a^ Data recorded in CD~3~OD; ^b^ Data recorded in C~5~D~5~N; \* The signal is overlapped by solvent.

![Key NOE (![](molecules-17-03324-i001.jpg)) correlations of **1** and **2**.](molecules-17-03324-g002){#molecules-17-03324-f002}

Compound **2** was also obtained as a white amorphous powder. HR-EIMS showed a \[M\]^+^ ion at *m/z* 578.3450, corresponding to the molecular formula C~32~H~50~O~9~ (calcd for C~32~H~50~O~9~, 578.3449). The spectroscopic data (IR, UV, and NMR: See [Section 3.3.](#sec3dot3-molecules-17-03324){ref-type="sec"} and [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}) suggested **2** was an ecdysteroid closely related to 20,22-*O*-(*R*-ethylidene)-20-hydroxyecdysone, a reported \[[@B24-molecules-17-03324],[@B25-molecules-17-03324]\] ecdysteroid which was also obtained in the present study (compound **4**). Further comparison of the ^1^H- and ^13^C-NMR spectra showed that the signals for the C~2~ acetal group in **4** were absent in **2**. Instead, additional signals for one acetalated 3-methoxycarbonyl-propylal group \[*δ*~H~ 4.97 (1H, t, H-1\'), 3.65 (3H, s, 4\'-OC[H]{.ul}~3~), 2.41 (3H, H~3~-3\'), 1.90 (3H, H~3~-2\'); *δ*~C~ 175.6 (C-4\'), 103.9 (C-1\'), 52.1 (4\'-O[C]{.ul}H~3~), 31.0 (C-3\')~,~ 29.2 (C-2\')\] were exhibited in the spectra. ^1^H-^1^H COSY and HSQC spectra permitted establishment of the spin system from C-1\' through C-3\'. The HMBC correlations from 4\'-OC[H]{.ul}~3~ (*δ*~H~ 3.65), H~2~-3\' (*δ*~H~ 2.41) and H~2~-2\' (*δ*~H~ 1.91) to C-4\' (*δ*~C~ 175.6), and from H~2~-2\', H~2~-3\' to C-1\' (*δ*~C~ 103.9) indicated the linkage from C-1\' to 4\'-O[C]{.ul}H~3~. The *R* configuration at C-1\' was determined by the important NOE correlation between H-1\' and H-22 ([Figure 2](#molecules-17-03324-f002){ref-type="fig"}). These findings led to the establishment of the whole structure of **2** as shown in [Figure 1](#molecules-17-03324-f001){ref-type="fig"}, and this structure was further well supported by other important ^1^H-^1^H COSY, HMBC and NOESY correlations. Therefore, **2** was determined as 20,22-*O*-(*R*-3-methoxycarbonyl)propylidene-20-hydroxyecdysone.

Compound **3**, showing the molecular formula C~28~H~44~O~7~, was deduced to be the same ecdysteroid compound inokosterone-20,22-acetonide from the roots of *Leuzea carthamoides* recently reported in the literature \[[@B22-molecules-17-03324]\], by comparison of its spectroscopic data ([Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}) with reported values. However, at that time the authors had yet not clarified the absolute configuration at C-25 in the structure. In order to determine the stereochemistry at C-25 in the structure of **3**, a similar acid hydrolysis like that performed for **1** was conducted, and the free ecdysteroid that was released from **3** was confirmed to be (25*S*)-inokosterone (**8**) on the basis of a co-TLC elution test and NMR analyses, suggesting that the absolute configuration at C-25 in **3** should also be *S* configuration. Therefore, the complete structure of **3** was determined as (25*S*)-inokosterone-20,22-acetonide.

The other five known compounds were identified as 20,22-*O*-(*R*-ethylidene)-20-hydroxyecdysone (**4**) \[[@B24-molecules-17-03324],[@B25-molecules-17-03324]\], 20-hydroxyecdysone-20,22-monoacetonide (**5**) \[[@B25-molecules-17-03324],[@B26-molecules-17-03324]\], 20-hydroxyecdysone (**6**) \[[@B27-molecules-17-03324]\], (25*R*)-inokosterone (**7**) \[[@B23-molecules-17-03324],[@B28-molecules-17-03324]\] and (25*S*)-inokosterone (**8**) \[[@B23-molecules-17-03324],[@B28-molecules-17-03324]\], by interpretation of their spectroscopic data, as well as by comparison with literature values.

Among the eight isolated compounds, **1** and **2** are two new phytoecdysteroids, each characterized by having an acetal group in the molecule. In particular, **2** is so far the first example of phytoecdysteroid acetalated at the side chain with a 4-oxobutanoic acid unit. Compounds **3**--**5** were found in *Achyranthes bidentata* roots for the first time.

3. Experimental
===============

3.1. General
------------

Optical rotations were measured on a Perkin-Elmer 341 polarimeter with MeOH as solvent. UV spectra were recorded in MeOH on a Perkin-Elmer Lambda 35 UV-Vis spectrophotometer. IR spectra (KBr) were taken on a Bruker Tensor 27 spectrophotometer in cm^−1^. NMR spectra were recorded in C~5~D~5~N and CD~3~OD on a Bruker DRX-400 instrument using the residual solvent peak as reference. ESIMS were collected on an MDS SCIEX API 2000 LC/MS/MS instrument. HRESIMS data were obtained on a Water Q-TOF Premier mass spectrometer and HREIMS data were obtained on a Finigan MAT 95XP mass spectrometer. Preparative HPLC was conducted using a CXTH P3000 HPLC pump and a UV3000 UV-Vis Detector with a Fuji-C18 column (10 µm--100 A). For column chromatography (CC), silica gel (200--300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), YMC ODS-A (50 μm, YMC Co. Ltd., Kyoto, Japan) and Sephadex LH-20 (Pharmacia Fine Chemical Co. Ltd., Uppsala, Sweden) were used. Fractions were monitored by TLC, and spots were visualized by heating the silica gel plates sprayed with 10% H~2~SO~4~ in ethanol.

3.2. Plant Materials
--------------------

Roots of *A. bidentata* Blume were purchased from Anguo Professional Market for Chinese Materia Medica, in April 2010, and were collected in Anguo County, Hebei Province, China. Plants were authenticated by Fu-Wu Xing (South China Botanical Garden, Chinese Academy of Sciences), and a voucher specimen (No. 20100408A) was deposited in the Laboratory of Phytochemistry of South China Botanical Garden, Chinese Academy of Sciences.

3.3. Extraction and Isolation {#sec3dot3-molecules-17-03324}
-----------------------------

Powder of the dry roots of *A. bidentata* (5.10 kg) was extracted with EtOH-H~2~O (95:5, 10 L × 3) at room temperature three times (24 h each). The EtOH extracts were combined and concentrated *in vacuo*. Then, the resulting residue was suspended in H~2~O (1.5 L) and sequentially extracted with petroleum ether (5 L × 3), EtOAc (5 L × 3) and *n*-BuOH (5 L × 3). The EtOAc layer was evaporated *in vacuo* to yield EtOAc-soluble fraction (17.5 g).

The EtOAc-soluble fraction was subjected to silica gel CC using a gradient of CHCl~3~-MeOH (95:5--60:40, v/v) to give ten fractions (E~1~--E~10~). Fraction E~8~ (3.90 g), obtained by elution with CHCl~3~-MeOH (85:15, v/v), was further subjected to silica gel CC and successively eluted with CHCl~3~-MeOH (20:1--10:1, v/v) to yield six sub-fractions (E~6--1~--E~6--6~). Sub-fraction E~6--4~ (0.370 g) was separated by an ODS column using MeOH-H~2~O (60:40--100:0, v/v), followed by HPLC preparation with MeOH-H~2~O (70:30, v/v) at a flow rate of 10 mL/min to afford compounds **2** (5.9 mg, t~R~ = 41 min), **4** (6.8 mg, t~R~ = 49 min), **3** (6.0 mg, t~R~ = 61 min), **1** (5.0 mg, t~R~ = 65 min), and **5** (9.3 mg, t~R~ = 67 min). Sub-fraction E~6--5~ (0.200 g ) was purified by Sephadex LH-20 CC using MeOH as eluent, followed by preparative HPLC using MeOH-H~2~O (40:60, v/v) at a flow rate of 8 mL/min to afford compounds **6** (t~R~ = 96 min, 20.0 mg), **7** (t~R~ = 114 min, 29.0 mg) and **8** (t~R~ = 127 min, 38.0 mg).

*(25S)-20,22-O-(R-Ethylidene)inokosterone* (**1**). White amorphous powder; \[α\]![](molecules-17-03324-i002.jpg) + 26.8 (c = 0.35, MeOH); IR (KBr) *ν*~max~ 3419, 2934, 1654 ,1450, 1139, 1156 cm^−1^; UV (MeOH) *λ*~max~ (log *ε*) nm: 242 (4.14); ESIMS (+) *m*/*z* 529 \[M+Na\]^+^, 507 \[M+H\]^+^; ESIMS (−) *m*/*z* 505 \[M--H\]^--^; HRESIMS (−) *m/z* 505.3173 \[M−H\]^--^ (calcd. for C~29~H~45~O~7~, 505.3160); ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data are shown in [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}.

*20,22-O-(R-3-Methoxycarbonyl)propylidene-20-hydroxyecdysone* (**2**). White amorphous powder; \[α\]![](molecules-17-03324-i003.jpg) + 34.0 (c = 0.20, MeOH); IR (KBr) *ν*~max~ 3423, 2964, 1737, 1654, 1382, 1139, 1058 cm^−1^; UV (MeOH) *λ*~max~ (log *ε*) nm: 242 (3.75); ESIMS (+) *m*/*z* 601 \[M+Na\]^+^, 579 \[M+H\]^+^; ESIMS (−) *m*/*z* 577 \[M−H\]^−^; HREIMS *m/z* 578.3450 \[M\]^+^ (calcd. for C~32~H~50~O~9~, 578.3449); ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data are shown in [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}.

*(25S)-Inokosterone-20,22-acetonide* (**3**). White amorphous powder; ESIMS (+) *m*/*z* 520 \[M+Na\]^+^; ESIMS (−) *m*/*z* 555 \[M+Cl\]^−^, 519 \[M−H\]^−^; ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data are shown in [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}.

*20,22-O-(R-Ethylidene)-20-hydroxyecdysone* (**4**). White amorphous powder; ESIMS (+) *m*/*z* 545 \[M+K\]^+^, 529 \[M+Na\]^+^; ESIMS (−) *m*/*z* 541 \[M+Cl\]^−^, 505 \[M−H\]^−^; ^1^H-NMR (CD~3~OD, 400 MHz) and ^13^C-NMR (CD~3~OD, 100 MHz) data are shown in [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}.

*(25S)-Inokosterone* (**8**). White amorphous powder; ESIMS (+) *m*/*z* 519 \[M+K\]^+^, 503 \[M+Na\]^+^; ESIMS (−) *m*/*z* 515 \[M+Cl\]^−^; ^1^H-NMR (C~5~D~5~N, 400 MHz) and ^13^C-NMR (C~5~D~5~N, 100 MHz) data are shown in [Table 1](#molecules-17-03324-t001){ref-type="table"} and [Table 2](#molecules-17-03324-t002){ref-type="table"}.

3.4. Acidic Hydrolysis of Compounds 1 and 3
-------------------------------------------

Individual solutions of **1** (2.5 mg) and **3** (3.0 mg) in 1 M H~2~SO~4~ (0.5 mL) were allowed to stand at room temperature for 12 h with continuous oscillation. Each reaction mixture was subsequently extracted with CHCl~3~ (1 mL) and EtOAc (1 mL × 3), and the EtOAc-soluble fraction was concentrated to dryness to give a free ecdysteroid (1.5 mg from **1** and 1.8 mg from **3**). Both hydrolysates were identified as the known compound (25S)-inokosterone (**8**).

4. Conclusions
==============

Two new phytoecdysteroids, (25*S*)-20,22-*O*-(*R*-ethylidene)inokosterone (**1**) and 20,22-*O*-(*R*-3-methoxycarbonyl)propylidene-20-hydroxyecdysone (**2**), were isolated from the roots of *Achyranthes bidentata* Blume, along with six known ones. Three out of the six known compounds **3**--**5** were found in this plant species for the first time. Compound **2** is so far the first example of phytoecdysteroid acetalated at the side chain with a 4-oxobutanoic acid unit. The absolute configuration at C-25 in the structure of known compound **3** was further established in this study.
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